{"name":"Seref istek","slug":"seref-istek","ticker":"","exchange":"","domain":"","description":"Seref Istek is a specialty pharmaceutical company focused on developing and marketing ophthalmic solutions. The company has two marketed drugs, AS 50% eye drops and COE 2*1 (Restasis) + PFAT Refresh Single dose, which are designed to address various eye conditions.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AS 50% eye drops 8*1","genericName":"AS 50% eye drops 8*1","slug":"as-50-eye-drops-8-1","indication":"Corneal edema (bullous keratopathy)","status":"marketed"}]}],"pipeline":[{"name":"AS 50% eye drops 8*1","genericName":"AS 50% eye drops 8*1","slug":"as-50-eye-drops-8-1","phase":"marketed","mechanism":"AS 50% eye drops provide osmotic dehydration of corneal edema by drawing fluid from the cornea into the anterior chamber.","indications":["Corneal edema (bullous keratopathy)","Temporary improvement of vision in corneal edema"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}